112
Views
16
CrossRef citations to date
0
Altmetric
Research Article

In vivo acute toxicological studies of an antioxidant extract from Mangifera indica L. (Vimang)

, , , , , , & show all
Pages 53-58 | Received 14 May 2008, Accepted 29 Oct 2008, Published online: 26 Jan 2009

References

  • Andreu GL, Delgado R, Velho J, Curti C, Vercesi AE (2005). Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur. J. Pharmacol. 513, 47–55.
  • Anjaneyulu V, Babu IS., Connolly JD (1994). 29-hydroxymangiferonic acid from Mangifera indica. Phytochemistry 35, 1301–1303.
  • Center of Pharmaceutical Chemistry. (2002). Pharmaceutical composition including a mixture of polyphenols, terpenoids, steroids, fatty acids, and microelements with antioxidant, analgesic, anti-inflammatory, and antispasmodic properties. Cuban Patent 203/98, OCPI, Havana, Cuba.
  • Coe FG, Anderson GL (1996). Screnning of medicinal plants used by the Garifuna of eastern Nicaragua for bioactive compounds. J. Ethnopharmacol 53, 29–50.
  • Draize JH Woodward G, Calvery HO (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Experl. Ther. 82, 377–390.
  • Eckstein P, Jackson MCN, Millman N, Sobrero AJ (1969). Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. J. Reprod.Fertil. 20, 85–93.
  • Garcia D, Delgado R, Ubeira F, Leiro J (2002). Modulation of rat macrophage function by the Mangifera indica L. extract Vimang and mangiferin. Intern. Immunopharmacol. 2, 797–806.
  • Garrido G, Gonzalez D, Delpote R, Backhouse N, Quintero G, Nuñez-Selles A (2001). Anagelsic and anti-inflammatory effects of Mangifera indica L. extract (VIMANG) Phytother. Res. 15, 18–21.
  • Garrido G, Delgado R, Lemus Y, Rodríguez J, Garcia D, Núñez A (2004a). Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Mangifera indica L. (VIMANG®). Role of mangiferin isolated from the extract. Pharmacol. Res. 50, 165–172.
  • Garrido G, Gonzalez D, Lemus Y, Garcia D, Lodeiro L, Quintero G et al. (2004b). In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (Vimang®). Pharmacol. Res. 50, 143–149.
  • Garrido G, Blanco-Molina M, Sancho R, Macho A, Delgado R, Muñoz E (2005). An aqueous stem bark extract of Mangifera indica (Vimang®) inhibits T cell proliferation and TNF-induced activation of nuclear transcription factor NF-kappaB. Phytother. Res. 19, 211–215.
  • Garrido G, Gonzalez D, Lemus Y, Delporte C, Delgado R (2006). Protective effects of a standard extract of Mangifera indica L. (VIMANG®) against mouse ear edemas and its inhibition of eicosanoid production in J774 murine macrophages. Phytomedicine 13, 412–418.
  • Guevara M, Riaño A, Alvarez A, Garrido G, Paez E, Delgado R (2002). Mangifera indica L. Uso etnomédico en Cuba. Rev. Cubana Farmacia 36, 166–168.
  • Kaminsky M, Willigan DA. (1982). pH and the potential irritancy of douche formulations to the vaginal mucosa of the albino rabbit and rat. Food. Cosmet. Toxicol. 20, 193–196.
  • Khan MA, Nizami SS, Khan MNI, Azeem SW, Ahmed Z (1994). New triterpenes from Mangifera indica. J Nat. Prod. 57, 988–991.
  • Leiro J, García D, Arranz J, Delgado R, Sanmartín M, Orallo F (2004). An Anacardiaceace preparation reduces the expression of inflammation-related genes in murine macrophages. Intern. Immunopharmacol. 4, 991–1003.
  • Martinez G, Delgado R, Perez G, Garrido G, Nuñez A, Leon O (2000a). Evaluation of the in vitro antioxidant activity of Mangifera indica L. extract (Vimang®). Phytother. Res. 14, 424–427.
  • Martínez SG., Jalil EC, Giuliani A, León FOS, Ram S, Delgado HR et al. (2000b). Mangifera indica L. extract (Vimang®) reduces ischaemia-induced neuronal loss and oxidative damage in gerbil brain. Free Radical Res. 32, 1–3.
  • Martínez SG., Giuliani A,León OS,Pérez DG,Núñez AJ. (2001). Effect of Mangifera indica L. extract (Vimang®) on protein and hepatic microsoma peroxidation. Phytother. Res. 15, 581–585.
  • Matulka RA, Hood AM, Griffiths JC (2004). Safety evaluation of a natural tomato oleoresin extract derived from food-processing tomatoes. Regul. Toxicol. Pharm. 39, 90–402.
  • Núñez A, Velez H, Aguero-Agüero J, Gonzalez I, Naddeo F, De Simone F et al. (2002). Isolation and quantitative analysis of phenolic antioxidants, free sugars, and polyphenols from mango (Mangifera indica L.) stem bark aqueous decoction used in Cuba as a nutritional supplement. J. Agr. Food Chem. 50, 762–766.
  • Nuñez AJ, Durruthy MD, Rodríguez E, Nieto L, Nicolais V, Rastrelli L (2007). Comparison of major and trace element concentration in sixteen varieties of Cuban mango stem bark (Mangifera indica L.). J. Agr. Food Chem. 55, 2176–2181.
  • OECD. (2000a). Guideline for the Testing of Chemicals, No. 423. Acute Oral Toxicity–Acute Toxic Class Method. Paris, France: Organization for Economic Cooperation and Development.
  • OECD. (2000b). OECD Guideline for Testing of Chemicals, No. 404. Acute Dermal Toxicity–Fixed Dose Procedure. Paris, France: Organization for Economic Cooperation and Development.
  • OECD. (2004). OECD Guideline for Testing of Chemicals, No. 434. Acute Dermal Toxicity–Fixed Dose Procedure. Paris, France: Organization for Economic Cooperation and Development.
  • Pardo-Andreu G, Delgado R, Núñez-Sellés AJ, Vercesi A E (2006a). Mangifera indica L. extract (Vimang®) inhibits 2-deoxyribose damage induced by Fe (III) plus ascorbate. Phytother. Res. 20, 120–124.
  • Pardo-Andreu GL, Sánchez-Baldoquín C, Avila-González R, Suzuki Yamamoto ET, Revilla A, Akira Uyemurad S et al. (2006b). Interaction of Vimang® (Mangifera indica L. extract) with Fe(III) improves its antioxidant and cytoprotecting activity. Pharmacol. Res. 53, 253–260.
  • Pardo-Andreu G, Sánchez-Baldoquín C, ávila-González R, Delgado R, Naal Z, Curti C (2006c). Fe(III) improves antioxidant and cytoprotecting activities of mangiferin. Eur. J. Pharmacol. 547, 31–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.